These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16048965)

  • 1. Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal fungicidal concentration.
    Majoros L; Kardos G; Szabó B; Sipiczki M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3486-8. PubMed ID: 16048965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.
    Maida CM; Milici ME; Oliveri S
    J Chemother; 2007 Jun; 19(3):277-82. PubMed ID: 17594922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.
    Cantón E; Pemán J; Gobernado M; Alvarez E; Baquero F; Cisterna R; Gil J; Martín-Mazuelos E; Rubio C; Sánchez-Sousa A; Serrano C
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1604-7. PubMed ID: 15793151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry susceptibility testing for the antifungal caspofungin.
    Mitchell M; Hudspeth M; Wright A
    J Clin Microbiol; 2005 Jun; 43(6):2586-9. PubMed ID: 15956368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of caspofungin against fluconazole-resistant Candida isolates from patients with HIV infection].
    Ortiz de la Tabla-Ducasse V; Masiá-Canuto M; Martín-González C; Gutiérrez-Rodero F
    Enferm Infecc Microbiol Clin; 2004; 22(6):328-31. PubMed ID: 15228899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
    Odds FC; Motyl M; Andrade R; Bille J; Cantón E; Cuenca-Estrella M; Davidson A; Durussel C; Ellis D; Foraker E; Fothergill AW; Ghannoum MA; Giacobbe RA; Gobernado M; Handke R; Laverdière M; Lee-Yang W; Merz WG; Ostrosky-Zeichner L; Pemán J; Perea S; Perfect JR; Pfaller MA; Proia L; Rex JH; Rinaldi MG; Rodriguez-Tudela JL; Schell WA; Shields C; Sutton DA; Verweij PE; Warnock DW
    J Clin Microbiol; 2004 Aug; 42(8):3475-82. PubMed ID: 15297486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.
    Kartsonis N; Killar J; Mixson L; Hoe CM; Sable C; Bartizal K; Motyl M
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3616-23. PubMed ID: 16127030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J; Armstrong D; Lyman CA; Walsh TJ
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
    Cocuaud C; Rodier MH; Daniault G; Imbert C
    J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Nov; 43(11):5425-7. PubMed ID: 16272464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Jul; 42(7):3117-9. PubMed ID: 15243069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of caspofungin against planktonic and sessile Candida sp. cells.
    Serefko A; Chudzik B; Malm A
    Pol J Microbiol; 2006; 55(2):133-7. PubMed ID: 17419291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
    Cota J; Carden M; Graybill JR; Najvar LK; Burgess DS; Wiederhold NP
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3926-8. PubMed ID: 16940061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods.
    Roling EE; Klepser ME; Wasson A; Lewis RE; Ernst EJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 May; 43(1):13-7. PubMed ID: 12052624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.